Evidence map›Paper›PMID 20075384›Full record

Trial reportAmerican journal of respiratory and critical care medicine2010

Vitamin D levels, lung function, and steroid response in adult asthma.

E Rand Sutherland, Elena Goleva, Leisa P Jackson, Allen D Stevens, Donald Y M Leung

3 registry-linked trialsOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 147 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed, 5 pooled it
25.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00495157 phase3completednot on this map

Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)

TypeinterventionalSponsorMilton S. Hershey Medical CenterRan2007 to 2010Enrolled342ConditionsAsthmaArmsSymptom-based adjustment, Biomarker-based adjustment, Guideline-based adjustment
NCT00557180 completednot on this map

Obesity, Inflammation and Response to Therapy in Asthma - Ancillary to Asthma Clinical Research Network (ACRN) Trials

TypeobservationalSponsorNational Jewish HealthRan2007 to 2011Enrolled33ConditionsAsthma, ObesityArmsBeclomethasone dipropionate HFA, Tiotropium bromide, Salmeterol xinafoate
NCT00565266 phase3completednot on this map

Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)

TypeinterventionalSponsorMilton S. Hershey Medical CenterRan2008 to 2010Enrolled210ConditionsAsthmaArmstiotropium bromide, salmeterol xinafoate, beclomethasone dipropionate
3 · Its place in the literature

Who cites it

147 citing papers in PubMed, 5 syntheses or guidelines pooled it, 380 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Drug-vitamin D interactions: a systematic review of the literature.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2013
    Pooled it
  6. Trial
  7. Association of free vitamin DAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2018
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. The effects of airway microbiome on corticosteroid responsiveness in asthma.American journal of respiratory and critical care medicine · 2013
    Trial
  12. Trial
  13. Effect of vitamin D and inhaled corticosteroid treatment on lung function in children.American journal of respiratory and critical care medicine · 2012
    Trial
  14. Trial
  15. Review
  16. Article
  17. Review
  18. Vitamin D3 suppresses NLRP3 inflammasome pathway and enhances steroid sensitivity in a neutrophilic steroid hyporesponsive asthma mouse model.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  19. Article
  20. Review

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

E Rand SutherlandDepartment of Medicine, University of Colorado, Denver, Colorado, USA. sutherlande@njhealth.org
Elena Goleva
Leisa P Jackson
Allen D Stevens
Donald Y M Leung
National Jewish Health · USUniversity of Colorado Denver · US

Funding

Innovative Investigations and Therapies for AsthmaU10HL074073 · NHLBI · NATIONAL JEWISH HEALTH · PI MARTIN, RICHARD J · 2003 to 2007
$3.9M
Mechanisms of steroid resistant asthmaR01AI070140 · NIAID · NATIONAL JEWISH HEALTH · PI LEUNG, DONALD YM · 2007 to 2011
$2.5M
Obesity, Inflammation and Response to Therapy in AsthmaR01HL090982 · NHLBI · NATIONAL JEWISH HEALTH · PI SUTHERLAND, EVERETT RAND · 2007 to 2010
$1.4M
Mechanisms of Steroid Resistant AsthmaR56AI070140 · NIAID · NATIONAL JEWISH HEALTH · PI GOLEVA, ELENA, LEUNG, DONALD YM · 2012 to 2012
$431k
NHLBI NIH HHS HL074073NHLBI NIH HHS HL090982NHLBI NIH HHS R01 HL090982NIAID NIH HHS AI070140
6 · The paper itself

Abstract

rationalePatients with asthma exhibit variable response to inhaled corticosteroids (ICS). Vitamin D is hypothesized to exert effects on phenotype and glucocorticoid (GC) response in asthma.

objectivesTo determine the effect of vitamin D levels on phenotype and GC response in asthma.

methodsNonsmoking adults with asthma were enrolled in a study assessing the relationship between serum 25(OH)D (vitamin D) concentrations and lung function, airway hyperresponsiveness (AHR), and GC response, as measured by dexamethasone-induced expression of mitogen-activated protein kinase phosphatase (MKP)-1 by peripheral blood mononuclear cells. MEASUREMENTS AND MAIN

resultsA total of 54 adults with asthma (FEV(1), 82.9 +/- 15.7% predicted [mean +/- SD], serum vitamin D levels of 28.1 +/- 10.2 ng/ml) were enrolled. Higher vitamin D levels were associated with greater lung function, with a 22.7 (+/-9.3) ml (mean +/- SE) increase in FEV(1) for each nanogram per milliliter increase in vitamin D (P = 0.02). Participants with vitamin D insufficiency (<30 ng/ml) demonstrated increased AHR, with a provocative concentration of methacholine inducing a 20% fall in FEV(1) of 1.03 (+/-0.2) mg/ml versus 1.92 (+/-0.2) mg/ml in those with vitamin D of 30 ng/ml or higher (P = 0.01). In ICS-untreated participants, dexamethasone-induced MKP-1 expression increased with higher vitamin D levels, with a 0.05 (+/-0.02)-fold increase (P = 0.02) in MKP-1 expression observed for each nanogram per milliliter increase in vitamin D, a finding that occurred in the absence of a significant increase in IL-10 expression.

conclusionsIn asthma, reduced vitamin D levels are associated with impaired lung function, increased AHR, and reduced GC response, suggesting that supplementation of vitamin D levels in patients with asthma may improve multiple parameters of asthma severity and treatment response. Clinical trials registered with www.clinicaltrials.gov (NCT00495157, NCT00565266, and NCT00557180).

Indexed as

Administration, InhalationAdultAsthmaBody Mass IndexBronchial HyperreactivityBronchodilator AgentsCell Growth ProcessesCross-Sectional StudiesDexamethasoneDrug InteractionsDual Specificity Phosphatase 1FemaleForced Expiratory VolumeGlucocorticoidsHumansInterleukin-10Bronchodilator AgentsDexamethasoneDual Specificity Phosphatase 1DUSP1 protein, humanGlucocorticoidsInterleukin-10Methacholine ChlorideTumor Necrosis Factor-alphaVitamin D

Identifiers

PMID20075384
PMCPMC2868500
OpenAlexW2103010959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.